Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 23, no: 6 |
NetGPI | no | yes: 0, no: 29 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0009986 | cell surface | 2 | 1 |
Related structures:
AlphaFold database: Q4Q7F3
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 30 |
GO:0006259 | DNA metabolic process | 4 | 30 |
GO:0006308 | DNA catabolic process | 5 | 30 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 30 |
GO:0006807 | nitrogen compound metabolic process | 2 | 30 |
GO:0008152 | metabolic process | 1 | 30 |
GO:0009056 | catabolic process | 2 | 30 |
GO:0009057 | macromolecule catabolic process | 4 | 30 |
GO:0009987 | cellular process | 1 | 30 |
GO:0019439 | aromatic compound catabolic process | 4 | 30 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 30 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 30 |
GO:0043170 | macromolecule metabolic process | 3 | 30 |
GO:0044237 | cellular metabolic process | 2 | 30 |
GO:0044238 | primary metabolic process | 2 | 30 |
GO:0044248 | cellular catabolic process | 3 | 30 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 30 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 30 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 30 |
GO:0046483 | heterocycle metabolic process | 3 | 30 |
GO:0046700 | heterocycle catabolic process | 4 | 30 |
GO:0071704 | organic substance metabolic process | 2 | 30 |
GO:0090304 | nucleic acid metabolic process | 4 | 30 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 30 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 30 |
GO:1901575 | organic substance catabolic process | 3 | 30 |
GO:0006163 | purine nucleotide metabolic process | 5 | 1 |
GO:0006195 | purine nucleotide catabolic process | 6 | 1 |
GO:0006196 | AMP catabolic process | 7 | 1 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0009117 | nucleotide metabolic process | 5 | 1 |
GO:0009123 | nucleoside monophosphate metabolic process | 5 | 1 |
GO:0009125 | nucleoside monophosphate catabolic process | 6 | 1 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 6 | 1 |
GO:0009128 | purine nucleoside monophosphate catabolic process | 7 | 1 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 1 |
GO:0009154 | purine ribonucleotide catabolic process | 6 | 1 |
GO:0009158 | ribonucleoside monophosphate catabolic process | 7 | 1 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 6 | 1 |
GO:0009166 | nucleotide catabolic process | 6 | 1 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 7 | 1 |
GO:0009169 | purine ribonucleoside monophosphate catabolic process | 8 | 1 |
GO:0009259 | ribonucleotide metabolic process | 5 | 1 |
GO:0009261 | ribonucleotide catabolic process | 5 | 1 |
GO:0019637 | organophosphate metabolic process | 3 | 1 |
GO:0019693 | ribose phosphate metabolic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0046033 | AMP metabolic process | 7 | 1 |
GO:0046434 | organophosphate catabolic process | 4 | 1 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 1 |
GO:0072521 | purine-containing compound metabolic process | 4 | 1 |
GO:0072523 | purine-containing compound catabolic process | 5 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
GO:1901136 | carbohydrate derivative catabolic process | 4 | 1 |
GO:1901292 | nucleoside phosphate catabolic process | 5 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 30 |
GO:0003824 | catalytic activity | 1 | 30 |
GO:0004518 | nuclease activity | 4 | 30 |
GO:0004519 | endonuclease activity | 5 | 30 |
GO:0005488 | binding | 1 | 30 |
GO:0016787 | hydrolase activity | 2 | 30 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 30 |
GO:0043167 | ion binding | 2 | 30 |
GO:0043169 | cation binding | 3 | 30 |
GO:0046872 | metal ion binding | 4 | 30 |
GO:0097159 | organic cyclic compound binding | 2 | 30 |
GO:1901363 | heterocyclic compound binding | 2 | 30 |
GO:0008252 | nucleotidase activity | 6 | 1 |
GO:0008254 | 3'-nucleotidase activity | 7 | 1 |
GO:0016791 | phosphatase activity | 5 | 1 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 262 | 266 | PF00656 | 0.220 |
CLV_C14_Caspase3-7 | 53 | 57 | PF00656 | 0.234 |
CLV_NRD_NRD_1 | 130 | 132 | PF00675 | 0.457 |
CLV_NRD_NRD_1 | 183 | 185 | PF00675 | 0.442 |
CLV_PCSK_FUR_1 | 202 | 206 | PF00082 | 0.524 |
CLV_PCSK_FUR_1 | 270 | 274 | PF00082 | 0.434 |
CLV_PCSK_FUR_1 | 311 | 315 | PF00082 | 0.394 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.447 |
CLV_PCSK_KEX2_1 | 183 | 185 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 204 | 206 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 272 | 274 | PF00082 | 0.604 |
CLV_PCSK_KEX2_1 | 313 | 315 | PF00082 | 0.631 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.511 |
CLV_PCSK_PC1ET2_1 | 183 | 185 | PF00082 | 0.413 |
CLV_PCSK_PC1ET2_1 | 204 | 206 | PF00082 | 0.524 |
CLV_PCSK_PC1ET2_1 | 272 | 274 | PF00082 | 0.603 |
CLV_PCSK_PC1ET2_1 | 313 | 315 | PF00082 | 0.646 |
CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.511 |
DEG_APCC_DBOX_1 | 7 | 15 | PF00400 | 0.466 |
DEG_SCF_FBW7_1 | 255 | 262 | PF00400 | 0.249 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 141 | 150 | PF00134 | 0.213 |
DOC_CYCLIN_yCln2_LP_2 | 7 | 13 | PF00134 | 0.685 |
DOC_MAPK_gen_1 | 130 | 138 | PF00069 | 0.302 |
DOC_MAPK_MEF2A_6 | 172 | 181 | PF00069 | 0.285 |
DOC_PP2B_LxvP_1 | 7 | 10 | PF13499 | 0.470 |
DOC_PP4_FxxP_1 | 98 | 101 | PF00568 | 0.234 |
DOC_USP7_MATH_1 | 67 | 71 | PF00917 | 0.356 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.405 |
DOC_WW_Pin1_4 | 255 | 260 | PF00397 | 0.249 |
DOC_WW_Pin1_4 | 68 | 73 | PF00397 | 0.352 |
LIG_14-3-3_CanoR_1 | 162 | 168 | PF00244 | 0.263 |
LIG_14-3-3_CanoR_1 | 205 | 210 | PF00244 | 0.310 |
LIG_14-3-3_CanoR_1 | 278 | 282 | PF00244 | 0.330 |
LIG_14-3-3_CanoR_1 | 8 | 14 | PF00244 | 0.612 |
LIG_14-3-3_CterR_2 | 311 | 316 | PF00244 | 0.398 |
LIG_APCC_ABBA_1 | 239 | 244 | PF00400 | 0.234 |
LIG_BRCT_BRCA1_1 | 244 | 248 | PF00533 | 0.371 |
LIG_BRCT_BRCA1_1 | 64 | 68 | PF00533 | 0.247 |
LIG_DLG_GKlike_1 | 205 | 212 | PF00625 | 0.249 |
LIG_eIF4E_1 | 284 | 290 | PF01652 | 0.369 |
LIG_FHA_1 | 108 | 114 | PF00498 | 0.358 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.591 |
LIG_FHA_2 | 225 | 231 | PF00498 | 0.392 |
LIG_FHA_2 | 232 | 238 | PF00498 | 0.401 |
LIG_FHA_2 | 260 | 266 | PF00498 | 0.384 |
LIG_LIR_Apic_2 | 224 | 229 | PF02991 | 0.312 |
LIG_LIR_Gen_1 | 208 | 217 | PF02991 | 0.339 |
LIG_LIR_Gen_1 | 94 | 102 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 208 | 212 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.284 |
LIG_LIR_Nem_3 | 94 | 98 | PF02991 | 0.333 |
LIG_LYPXL_yS_3 | 254 | 257 | PF13949 | 0.335 |
LIG_NRBOX | 285 | 291 | PF00104 | 0.339 |
LIG_REV1ctd_RIR_1 | 95 | 100 | PF16727 | 0.192 |
LIG_RPA_C_Fungi | 118 | 130 | PF08784 | 0.227 |
LIG_SH2_CRK | 203 | 207 | PF00017 | 0.395 |
LIG_SH2_NCK_1 | 90 | 94 | PF00017 | 0.254 |
LIG_SH2_STAP1 | 163 | 167 | PF00017 | 0.448 |
LIG_SH2_STAP1 | 209 | 213 | PF00017 | 0.277 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.275 |
LIG_SH2_STAT5 | 209 | 212 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 226 | 229 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 267 | 270 | PF00017 | 0.275 |
LIG_SH2_STAT5 | 288 | 291 | PF00017 | 0.416 |
LIG_SH3_3 | 292 | 298 | PF00018 | 0.448 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.354 |
LIG_SUMO_SIM_anti_2 | 234 | 240 | PF11976 | 0.410 |
LIG_SUMO_SIM_par_1 | 15 | 21 | PF11976 | 0.591 |
LIG_SUMO_SIM_par_1 | 237 | 245 | PF11976 | 0.236 |
LIG_TYR_ITIM | 207 | 212 | PF00017 | 0.396 |
LIG_TYR_ITSM | 250 | 257 | PF00017 | 0.257 |
LIG_WW_1 | 200 | 203 | PF00397 | 0.277 |
LIG_WW_3 | 199 | 203 | PF00397 | 0.402 |
MOD_CDK_SPxK_1 | 196 | 202 | PF00069 | 0.262 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.342 |
MOD_CK2_1 | 224 | 230 | PF00069 | 0.427 |
MOD_Cter_Amidation | 181 | 184 | PF01082 | 0.277 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.495 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.663 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.320 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.398 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.274 |
MOD_GSK3_1 | 255 | 262 | PF00069 | 0.410 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.357 |
MOD_N-GLC_1 | 250 | 255 | PF02516 | 0.400 |
MOD_N-GLC_2 | 194 | 196 | PF02516 | 0.297 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.438 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.214 |
MOD_NEK2_1 | 17 | 22 | PF00069 | 0.557 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.372 |
MOD_NEK2_1 | 62 | 67 | PF00069 | 0.290 |
MOD_PKA_2 | 129 | 135 | PF00069 | 0.346 |
MOD_PKA_2 | 161 | 167 | PF00069 | 0.297 |
MOD_PKA_2 | 277 | 283 | PF00069 | 0.407 |
MOD_Plk_1 | 242 | 248 | PF00069 | 0.374 |
MOD_Plk_1 | 250 | 256 | PF00069 | 0.387 |
MOD_Plk_1 | 300 | 306 | PF00069 | 0.470 |
MOD_Plk_2-3 | 224 | 230 | PF00069 | 0.271 |
MOD_Plk_2-3 | 300 | 306 | PF00069 | 0.340 |
MOD_Plk_4 | 9 | 15 | PF00069 | 0.489 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.496 |
MOD_ProDKin_1 | 255 | 261 | PF00069 | 0.277 |
MOD_ProDKin_1 | 68 | 74 | PF00069 | 0.422 |
TRG_DiLeu_BaLyEn_6 | 218 | 223 | PF01217 | 0.297 |
TRG_ENDOCYTIC_2 | 209 | 212 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.329 |
TRG_ER_diArg_1 | 129 | 131 | PF00400 | 0.290 |
TRG_NES_CRM1_1 | 230 | 244 | PF08389 | 0.257 |
TRG_Pf-PMV_PEXEL_1 | 233 | 237 | PF00026 | 0.257 |
TRG_Pf-PMV_PEXEL_1 | 45 | 49 | PF00026 | 0.326 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I8Q7 | Leptomonas seymouri | 57% | 88% |
A0A0S4JAL3 | Bodo saltans | 38% | 93% |
A0A0S4JML7 | Bodo saltans | 32% | 87% |
A0A1X0P2K7 | Trypanosomatidae | 42% | 96% |
A0A3Q8IBF6 | Leishmania donovani | 37% | 83% |
A0A3Q8IEW3 | Leishmania donovani | 86% | 100% |
A0A3Q8IFH4 | Leishmania donovani | 38% | 84% |
A0A3Q8IK90 | Leishmania donovani | 37% | 91% |
A0A3S7X3A6 | Leishmania donovani | 84% | 100% |
A0A422N7B0 | Trypanosoma rangeli | 43% | 96% |
A4H6V5 | Leishmania braziliensis | 39% | 84% |
A4HI96 | Leishmania braziliensis | 63% | 96% |
A4HJL3 | Leishmania braziliensis | 39% | 83% |
A4I5I0 | Leishmania infantum | 84% | 100% |
A4I736 | Leishmania infantum | 38% | 84% |
C9ZQH5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
C9ZQH6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
C9ZQW0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 97% |
E9AGC7 | Leishmania infantum | 37% | 83% |
E9ANW7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 83% |
E9B0S4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
E9B0S5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 100% |
E9B231 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 38% | 84% |
F4JJL0 | Arabidopsis thaliana | 27% | 100% |
F4JJL3 | Arabidopsis thaliana | 27% | 100% |
P24021 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 24% | 100% |
Q4Q630 | Leishmania major | 36% | 100% |
Q4Q7F4 | Leishmania major | 99% | 100% |
Q4QGQ3 | Leishmania major | 38% | 100% |
Q66VY6 | Leishmania major | 37% | 100% |
Q8LDW6 | Arabidopsis thaliana | 27% | 100% |
Q9C9G4 | Arabidopsis thaliana | 27% | 100% |
Q9SXA6 | Arabidopsis thaliana | 26% | 100% |
V5B8Z9 | Trypanosoma cruzi | 43% | 81% |